Monoclonal gammapathies in Tunisia: Epidemiological, immunochemical and etiological analysis of 288 cases;Gammapathies monoclonales en Tunisie: Analyse épidé miologique, immunochimique et étiologique d'une série de 288 cas

Pathologie Biologie

Volumn 53, Issue 1, 2005, Pages 19-25

  Mseddi Hdiji, S ^a   Haddouk, S ^b   Ben Ayed, M ^b   Tahri, N ^a   Elloumi, M ^a   Baklouti, S ^a   Hachicha, J ^a   Krichen, M S ^a   Bahloul, Z ^a   Masmoudi, H ^b  

^a HEDI CHAKER HOSPITAL   (Tunisia)

^b HABIB BOURGUIBA HOSPITAL   (Tunisia)

Author keywords

Diagnosis; Diagnostic; pid miologie; Epidemiology; Gammapathie monoclonale; GMSI; Isotype; MGUS; Monoclonal gammapathy; My lome; Myeloma

Indexed keywords

IMMUNOGLOBULIN A; IMMUNOGLOBULIN D; IMMUNOGLOBULIN G; IMMUNOGLOBULIN LIGHT CHAIN; IMMUNOGLOBULIN M;

ADOLESCENT; ADULT; AGAR GEL ELECTROPHORESIS; AGED; AMYLOIDOSIS; ARTICLE; AUTOIMMUNE DISEASE; BLOOD DISEASE; CHILD; CHRONIC LYMPHATIC LEUKEMIA; DISEASE ASSOCIATION; EPIDEMIOLOGICAL DATA; FEMALE; HEAVY CHAIN DISEASE; HUMAN; IMMUNOHISTOCHEMISTRY; INFECTION; KIDNEY FAILURE; LYMPHOMA; MALE; MONOCLONAL IMMUNOGLOBULINEMIA; MYELOMA; PERTHES DISEASE; PLASMACYTOMA; RHEUMATIC DISEASE; TUNISIA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AMYLOIDOSIS; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; IMMUNOCHEMISTRY; IMMUNOGLOBULIN LIGHT CHAINS; IMMUNOGLOBULIN M; INFANT; INFECTION; MALE; MIDDLE AGED; MULTIPLE MYELOMA; NEOPLASMS; PARAPROTEINEMIAS; TUNISIA;

EID: 19944380423     PISSN: 03698114     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.patbio.2004.01.014     Document Type: Article

References (24)

1. Brigden M.L. The search for meaning in monoclonal protein. Is it multiple myeloma or monoclonal gammopathy of undetermined significance? Postgraduate Medicine. 106:(2):August 1999;135-142
2. Boccardoro M., Pileri A. Plasma cell dyscrasias: classification, clinical and laboratory characteristics, and differential diagnosis. Baillière's Clinical Haematology. 8:(4):December 1995;705-719
3. Kyle R.A. Sequence of testing for monoclonal gammopathies: serum and urine assays. Arch. Pathol. Lab. Med. 123:February 1999;114-118
4. David F.K. Procedures for the evaluation of monoclonal immunoglobulins. Arch. Pathol. Lab. Med. 123:February 1999;126-132
5. Myara I. Rôle actuel du laboratoire dans la mise en évidence et le suivi d'une immunoglobulinopathie monoclonale. Path Biol. 38:(2):1990;134-143
6. Fine J.M., Lambin P., Derycke C., Muller J.Y., Marneux M. Systematic survery of monoclonal gammapathies in the sera from blood donors. Transfusion, USA. 19:1979;332
7. Youinou P., Jouquan J., Gérard C. Les gammapathies monoclonales non malignes. Revue française de transfusion et immuno- hématologie. 2:(Tome XXIX):1986;81-97
8. Makni S., Zouari R., Barbouch M.R., Ayed K., Moalla M., Zakraoui L. Gammapathies monoclonales en Tunisie. Rev. Fr. Transfus; Hemobiol. 33:1990;31-38
9. Yvette I.L., Chow J., Wickham N.W.R. Monoclonal gammopathy of unknown significance and malignant paraproteinemia in Hong Kong. AJCP. 106:(4):Oct 1996;449-456
10. ONG F., Hermans J., Noordijk E.M., Wijermans P.W., Seelen P.J., De Kieviet W., et al. A population-based registry on paraportéinaemia in the netherlands. British Journal of Haematology. 99:1997;914-920
11. Hurez D. Épidémiologie des gammapathies monoclonales. Rev Prat (Paris). 43:(3):1993;271-274
12. Kyle R.A. Subject review. Multiple myeloma: review of 869 cases. Mayo Clin Proc. 50:Jan 1975;29-40
13. Kyle R.A. Monoclonal gammapathy of undertemined significance and sonoldering multiple myeloma. Eur. J. Haematol. 43:(Suppl 51):1989;70-75
14. Fine J.M., Marneux M. Données récentes sur les gammapathies monoclonales. Revue Française de transfusion et immuno- hématologie. 6:(Tome XXVIII):1985;560-591
15. Hurez D., Youinou P., Gombert J., Preud'homme J.L. Survery of monoclonal gammpathy in western France: incidence and unexpected high frequency of IgM. Immunology. 56:1985;557-560
16. Oberdofer A., Schnauffer K., Lange H.J., Neiss A. Zur Verteilung von Paraproteinämien nach Geschlecht und Alter der patienten, Paraprotein-klassen - subkassen und - leichketten-typen Z. Klin Chem. 196:1973;361-367
17. Pick A.I., Shoenfeld Y., Frohlichmann R., Weiss H., Vana D., Schereibman S. Plasma cell dyscrasia. Analysis of 423 patients. Jama. 241:(21):May 25, 1979;2275-2278
18. Giraldo M.P., Rubio-Felix D., Perella M. Monoclonal gammopathies of undetermined significance. Sangre (Barcelona). 36:1991;377-382. Clinical course and biological aspects of 397 cases
19. o 8):1977;517-521
20. Vittore M., de Francesco D., Banfi G., Porta F.A., Riches Pamela G. Laboratory investigation of monoclonal gammopathy during ten years of screening in a general hospital. J. Clin. Pathol. 40:1987;793-797
21. Kyle R.A. Monoclonal gammapathy of undertemined significance and solitary plasmocytoma: implications for progression to overt multiple myeloma. Hematol Oncol Clin North Am. 11:(1):1997;71-87
22. Bergsagel D. The incidence and epidemiology of plasma cell neoplasms. Stem Cells. 13:(suppl 2):1995;1-9
23. Kyle R.A. "Benign" Monoclonal gammopathy-After 20 to 35 years of follow-up. Mayo Clin Proc. 68:1993;26-36
24. Kyle R.A. Monoclonal gammopathy of undertermined significance (MGUS). Baillière's Clinical Haematology. 8:(4):December 1995;761-781